Friday, 12 April 2019

Novo Nordisk and Gilead team up to test fatty liver disease treatment

Novo Nordisk and Gilead Sciences will join forces on a clinical trial combining drugs from the two pharmaceutical firms to treat a progressive fatty liver disease known as NASH.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)